Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Share Buyback Program

19 Dec 2025 07:21

RNS Number : 2789M
Banco Bilbao Vizcaya Argentaria SA
19 December 2025
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Company"), in compliance with the Spanish Securities Market legislation, hereby proceeds to notify the following:

 

 

INSIDE INFORMATION

 

Further to the notice of inside information of 16 October 2025, with CNMV registration number 2942, BBVA has received the required authorization from the European Central Bank for the buyback and cancellation of own shares of BBVA for a maximum aggregate amount of 3,960 million euros, in one or several tranches and until 8 December 2026 (the "Authorization"). The maximum amount of 3,960 million euros has been fully deducted from BBVA's individual and consolidated common equity tier 1 (CET1) as from the Authorization receipt.

 

Once the Authorization has been obtained, and in exercise of the authority delegated to it by the Annual Shareholders' Meeting of BBVA held on 18 March 2022, the Board of Directors of BBVA, in its meeting held on 18 December 2025, has agreed to carry out a program scheme for the buyback of own shares in accordance with the provisions of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016 (together the "Regulations"), which will be executed in several tranches, for a maximum aggregate amount of up to 3,960 million euros, aimed at reducing BBVA's share capital (the "Program Scheme"), notwithstanding the possibility to suspend or early terminate the Program Scheme upon the occurrence of circumstances that make it advisable.

 

Likewise, the Board of Directors has agreed, within the scope of the Program Scheme, to carry out a first tranche in accordance with the provisions of the Regulations with a view to reducing the share capital of BBVA (the "First Tranche") and with the terms and conditions detailed below:

Purpose:

To reduce BBVA's share capital by cancelling the shares acquired.

 

Maximum cash amount:

 

The maximum aggregate cash amount will be 1,500,000,000 euros.

Maximum number of shares:

The maximum number of BBVA shares to be acquired will be 557,316,433.

 

Start of the execution:

Execution will start on 22 December 2025.

End of the execution:

The First Tranche will end neither before 6 March 2026 nor later than 7 April 2026[1] and, in any event, when within such period the maximum cash amount is reached or the maximum number of shares is acquired.

 

However, the Company reserves the right to temporarily suspend execution of the First Tranche or end it early in the event of any circumstance that so advises or requires.

 

Trading Venues:

Purchases shall be made on the Spanish electronic trading system - Continuous Market and on the Cboe Europe, Turquoise Europe and Aquis Exchange trading platforms.

 

Manager:

The First Tranche will be executed externally through J.P. Morgan SE, which will decide independently of the Company on the timing of the purchases of BBVA shares.

 

Minimum Number of Shares Per Day

The Manager shall purchase at least 500,000 BBVA shares on each Trading Day (which is not an Excluded Day nor a Disrupted Day[2]), unless the Manager determines that it would not be possible to achieve the Minimum Number of Shares Per Day without breaching the restrictions and limitations under Delegated Regulation (EU) 2016/1052. Any such occurrence shall be duly disclosed in the periodic communications made in accordance with the Regulations, stating the reason why the Minimum Number of Shares Per Day was not purchased.

 

Other conditions:

The own shares will be purchased observing in all cases the conditions and limits established in the Regulations.

 

The share purchase transactions performed, as well as the end or, as the case may be, the temporary suspension of execution of the First Tranche, will be duly communicated in accordance with the Regulations.

 

 

Madrid, 19 December 2025


[1] However, for each "Excluded Day," the execution period may be postponed by one "Trading Day," up to a maximum postponement until 21 April 2026.

 

A "Trading Day" means each day on which the Continuous Market is scheduled to be open for trading during normal market hours.

 

An "Excluded Day" means any Trading Day on which: (i) any Trading Venue does not open for the entire regular trading session; or (ii) a suspension or limitation on the trading of BBVA shares is imposed on any Trading Venue for the entire regular trading session; or (iii) the trading price of BBVA shares on any Trading Venue is below their nominal value for the entire regular trading session; or (iv) the Company has suspended the execution of the First Tranche.

 

[2] "Disrupted Day" means any Trading Day on which: (i) any Trading Venue is closed for a substantial part of its regular trading session or closes significantly earlier than its scheduled closing time, or there is a significant disruption to trading on any Trading Venue; or (ii) any Trading Venue imposes a suspension or limitation on the trading of BBVA shares for a substantial part of the regular trading session; or (iii) the trading price of BBVA shares on any Trading Venue is below their nominal value for a substantial part of the regular trading session.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKABRVWUUARA
Date   Source Headline
30th Oct 20158:16 amRNSAdmission to trading share
30th Oct 20157:23 amRNSResults Presentation 3Q15
30th Oct 20157:22 amRNSFolleto Results
30th Oct 20157:00 amRNSPress Release
30th Oct 20157:00 amRNSDividend Option
27th Oct 20157:00 amRNS3T15 Results Pres. Announcement
20th Oct 20157:00 amRNSEnding trading Dividend Option
13th Oct 20156:01 pmRNSS&P rating actions
12th Oct 20159:57 amRNSSupplement to ECP Programme
6th Oct 20154:35 pmRNSBBVA´s rating upgraded by S&P
1st Oct 20157:00 amRNSDividend Option Inf, Oct 2015
18th Sep 20155:18 pmRNSDividend Option Calendar Oct2015
27th Aug 20159:05 amRNSHR Closing sale of 29,68% CNCB
31st Jul 20158:38 amRNSAnalyst´s presentation 2nd quarter results 2015
31st Jul 20157:00 amRNSInformation for the semester January-June 2015
31st Jul 20157:00 amRNSHR Press Release Resulta BBVA 2Q15
27th Jul 201510:12 amRNSClosing acquisition of 14.89% Garanti
24th Jul 20155:15 pmRNS2Q15 Results presentation announcement
14th Jul 20159:40 amRNSReduction tax dividend July 2015
1st Jul 20155:35 pmRNSDividend July 2015
1st Jul 201512:49 pmRNSOffering Circular GMTN 2015
24th Jun 20151:07 pmRNSFORM 20-F
18th Jun 20157:00 amRNSReview of BBVA´s rating by Moody´s
29th May 20157:00 amRNSAppointment Eduardo Osuna Country Manager Mexico
5th May 20157:01 amRNSChanges in the Committees of the Board
5th May 20157:01 amRNSAppointment of President & COO and new structure
30th Apr 201511:01 amRNSDividend Option. Capital Increase
29th Apr 20158:43 amRNSResults 1STQ 2015:Analysts presentation
29th Apr 20157:00 amRNSPress release and 1stq report year 2015
28th Apr 201512:22 pmRNSPublication of Financial Statements
24th Apr 20155:52 pmRNS1Q15 results presentation announcement
24th Apr 201510:30 amRNSPublication of Prospectus
14th Apr 20155:29 pmRNSDividend Declaration
26th Mar 20154:30 pmRNSPost-Stabilisation Announcement_BBVA AT1
26th Mar 20157:00 amRNSDividend Option
17th Mar 201511:30 amRNSIRP Basel Accord Pillar III 2014
13th Mar 20156:22 pmRNSDividend Option
13th Mar 20156:05 pmRNSRESOLUTION PASSED
12th Mar 20158:40 amRNSChina CITIC Bank Corporation Limited
11th Feb 20157:00 amRNSPerpetual contingent convertible securities
10th Feb 20158:05 amRNSPre-Stabilisation Notice BBVA AT1
10th Feb 20157:00 amRNSReplacement:Proposed resolutions and annual report
9th Feb 201512:46 pmRNSProposed resolutions and annual reports
4th Feb 201510:41 amRNSREPLACEMENT:RESULTS YEAR 2014: ANALYSTS PRESENTATI
4th Feb 20159:09 amRNSResults years 2014:Analysts presentation
4th Feb 20157:40 amRNSPress realese and group information 2014
4th Feb 20157:00 amRNSAGM Statement
29th Jan 20155:24 pmRNSResults of BBVA for 4Q will be presented
23rd Jan 20159:49 amRNSSale 4.9% in China CITIC Bank
22nd Jan 20157:00 amRNSMOODY'S: BBVA's rating

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.